Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Celularity (CELU) Shares Outstanding (Weighted Average) (2020 - 2025)

Celularity (CELU) has disclosed Shares Outstanding (Weighted Average) for 6 consecutive years, with $24.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 13.28% to $24.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $24.6 million, a 13.28% increase, with the full-year FY2024 number at $21.9 million, up 22.89% from a year prior.
  • Shares Outstanding (Weighted Average) was $24.6 million for Q3 2025 at Celularity, up from $24.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $135.3 million in Q2 2022 to a low of $15.5 million in Q1 2023.
  • A 5-year average of $37.9 million and a median of $22.7 million in 2024 define the central range for Shares Outstanding (Weighted Average).
  • Peak YoY movement for Shares Outstanding (Weighted Average): surged 463.94% in 2022, then plummeted 88.09% in 2023.
  • Celularity's Shares Outstanding (Weighted Average) stood at $67.1 million in 2021, then skyrocketed by 101.77% to $135.3 million in 2022, then crashed by 86.83% to $17.8 million in 2023, then increased by 22.89% to $21.9 million in 2024, then grew by 12.59% to $24.6 million in 2025.
  • Per Business Quant, the three most recent readings for CELU's Shares Outstanding (Weighted Average) are $24.6 million (Q3 2025), $24.0 million (Q2 2025), and $23.5 million (Q1 2025).